Security
Xeris Biopharma Holdings, Inc. Common Stock · XERS
XERSNASDAQCommon stockCurrentCIK 1867096Updated Oct 3, 2026
XERS price & chart
Loading TradingView…
NASDAQ:XERS on TradingView ↗In the news
No coverage from other publishers is available.
Recent filings
4 filing
144 filing
Regulation FD Disclosure
Items 7.01, 9.01
4 filing
4 filing
Show 5 more recent filings
Financials
FY 2025 · USDSource
Source
Source
Source
Source
Source
balance sheet · annual statements
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|
| ASSETS | ||||
| AssetsUSD | 383,527,000Source | 323,060,000Source | 322,602,000Source | 344,522,000Source |
| Property, Plant and Equipment, NetUSD | 4,945,000Source | 5,562,000Source | 5,971,000Source | 5,516,000Source |
| GoodwillUSD | 22,859,000Source | 22,859,000Source | 22,859,000Source | 22,859,000Source |
| Intangible Assets, Net (Excluding Goodwill)USD | 88,078,000Source | 98,921,000Source | 109,764,000Source | 120,607,000Source |
| Current assets: | ||||
| Cash and Cash Equivalents, at Carrying ValueUSD | 111,042,000Source | 71,621,000Source | 67,449,000Source | 121,966,000Source |
| Accounts Receivable, after Allowance for Credit Loss, CurrentUSD | 51,050,000Source | 40,415,000Source | 39,197,000Source | 30,830,000Source |
| Inventory, NetUSD | 68,673,000Source | 48,175,000Source | 38,838,000Source | 24,735,000Source |
| Assets, CurrentUSD | 240,313,000Source | 167,662,000Source | 156,264,000Source | 186,818,000Source |
| Operating Lease, Right-of-Use AssetUSD | 22,112,000Source | 22,649,000Source | 23,204,000Source | 3,992,000Source |
| Other Assets, NoncurrentUSD | 5,220,000Source | 5,407,000Source | 4,540,000Source | 4,730,000Source |
| LIABILITIES AND EQUITY | ||||
| LiabilitiesUSD | 369,838,000Source | 352,675,000Source | 329,384,000Source | 299,335,000Source |
| Stockholders’ equity: | ||||
| Preferred Stock, Value, IssuedUSD | 0Source | 0Source | 0Source | 0Source |
| Common Stock, Value, IssuedUSD | 17,000Source | 15,000Source | 14,000Source | 14,000Source |
| Additional Paid in CapitalUSD | 685,004,000Source | 642,256,000Source | 610,254,000Source | 599,966,000Source |
| Retained Earnings (Accumulated Deficit)USD | -671,307,000Source | -671,861,000Source | -617,025,000Source | -554,770,000Source |
| Accumulated Other Comprehensive Income (Loss), Net of TaxUSD | -25,000Source | -25,000Source | -25,000Source | -23,000Source |
| Stockholders' Equity Attributable to ParentUSD | 13,689,000Source | -29,615,000Source | -6,782,000Source | 45,187,000Source |
| Liabilities and EquityUSD | 383,527,000Source | 323,060,000Source | 322,602,000Source | 344,522,000Source |
| Current liabilities: | ||||
| Liabilities, CurrentUSD | 109,574,000Source | 100,443,000Source | 95,193,000Source | 73,621,000Source |
| Operating Lease, Liability, CurrentUSD | 6,232,000Source | 6,080,000Source | 3,495,000Source | 1,580,000Source |
| Accounts Payable, CurrentUSD | 3,076,000Source | 2,290,000Source | 11,565,000Source | 4,606,000Source |
| Operating Lease, Liability, NoncurrentUSD | 31,531,000Source | 33,259,000Source | 34,764,000Source | 9,402,000Source |
| Deferred Income Tax Liabilities, NetUSD | — | 0Source | 2,268,000Source | 3,518,000Source |
| Other Liabilities, NoncurrentUSD | 8,398,000Source | 1,967,000Source | 4,848,000Source | 31,000Source |
| Additional Financial Items | ||||
| Accrued Liabilities, CurrentUSD | 33,155,000Source | 27,716,000Source | 23,510,000Source | 36,786,000Source |
| Deferred Tax Liabilities, NetUSD | 0Source | 0Source | 2,269,000Source | 3,518,000Source |
| Long-term Debt, Excluding Current MaturitiesUSD | 220,335,000Source | — | 190,932,000Source | 187,075,000Source |
| Long-term Debt, Current MaturitiesUSD | 0Source | 15,102,000Source | — | — |
| Long-term Debt, Excluding Current MaturitiesUSD | 220,335,000Source | 217,006,000Source | — | — |
| Short-term InvestmentsUSD | — | 0Source | 5,002,000Source | 0Source |
cash flow · annual statements
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|
| Cash flows from operating activities: | ||||
| Adjustments to reconcile net income to net cash provided by operating activities: | ||||
| Depreciation, Depletion and AmortizationUSD | 1,313,000Source | 1,227,000Source | 1,487,000Source | 1,399,000Source |
| Share-based Payment Arrangement, Noncash ExpenseUSD | 22,366,000Source | 18,363,000Source | 10,716,000Source | 12,160,000Source |
| Changes in operating assets and liabilities: | ||||
| Increase (Decrease) in Accounts ReceivableUSD | 10,635,000Source | 1,218,000Source | 8,367,000Source | 13,374,000Source |
| Increase (Decrease) in InventoriesUSD | 19,286,000Source | 8,782,000Source | 14,804,000Source | 7,465,000Source |
| Increase (Decrease) in Accounts PayableUSD | -69,000Source | -9,613,000Source | 6,959,000Source | -4,318,000Source |
| Deferred Income Tax Expense (Benefit)USD | 0Source | -2,268,000Source | -1,249,000Source | -1,424,000Source |
| Net Cash Provided by (Used in) Operating ActivitiesUSD | 28,626,000Source | -36,981,000Source | -47,023,000Source | -102,891,000Source |
| Cash flows from investing activities: | ||||
| Net Cash Provided by (Used in) Investing ActivitiesUSD | -696,000Source | 4,883,000Source | -6,004,000Source | 34,461,000Source |
| Cash flows from financing activities: | ||||
| Payment, Tax Withholding, Share-based Payment ArrangementUSD | 10,876,000Source | 3,734,000Source | 1,009,000Source | 468,000Source |
| Net Cash Provided by (Used in) Financing ActivitiesUSD | 11,389,000Source | 36,168,000Source | -1,613,000Source | 127,473,000Source |
| Repayments of Long-term DebtUSD | — | 0Source | 0Source | 43,496,000Source |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate EffectUSD | 39,319,000Source | 4,070,000Source | -54,640,000Source | 59,043,000Source |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash EquivalentsUSD | 115,063,000Source | 75,744,000Source | 71,674,000Source | 126,314,000Source |
| Supplemental disclosure of cash flow information: | ||||
| Interest Paid, Excluding Capitalized Interest, Operating ActivitiesUSD | 27,120,000Source | 26,948,000Source | 27,686,000Source | 10,859,000Source |
| Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash EquivalentsUSD | — | — | 0Source | 0Source |
| Additional Financial Items | ||||
| Share-based Payment Arrangement, ExpenseUSD | 22,366,000Source | 18,363,000Source | 10,716,000Source | 12,160,000Source |
| Amortization of Debt Issuance CostsUSD | 3,373,000Source | 3,007,000Source | 2,205,000Source | 1,559,000Source |
| Amortization of Intangible AssetsUSD | 10,843,000Source | 10,843,000Source | 10,843,000Source | 10,843,000Source |
| Gain (Loss) on Disposition of Property Plant EquipmentUSD | — | -91,000Source | -321,000Source | -236,000Source |
| Gain (Loss) on Extinguishment of DebtUSD | 0Source | 0Source | -2,837,000Source | -1,223,000Source |
| GoodwillUSD | 22,859,000Source | 22,859,000Source | 22,859,000Source | 22,859,000Source |
| Income Tax Expense (Benefit)USD | 0Source | -2,268,000Source | -1,249,000Source | -1,424,000Source |
| InterestExpenseNonoperatingUSD | 29,084,000Source | 30,485,000Source | — | — |
| Net Income (Loss) Attributable to ParentUSD | 554,000Source | -54,836,000Source | -62,255,000Source | -94,660,000Source |
| Net Income (Loss) Available to Common Stockholders, BasicUSD | 554,000Source | — | — | — |
| Operating Costs and ExpensesUSD | 266,949,000Source | 236,716,000Source | 207,924,000Source | 192,188,000Source |
| Operating Lease, ExpenseUSD | 5,163,000Source | 5,276,000Source | 4,474,000Source | 1,799,000Source |
| Other Nonoperating Income (Expense)USD | -24,342,000Source | -23,458,000Source | -19,494,000Source | -14,144,000Source |
| Payments to Acquire InvestmentsUSD | 0Source | 34,485,000Source | 43,741,000Source | 0Source |
| Proceeds from Issuance of Common StockUSD | — | 0Source | 0Source | 30,000,000Source |
| Proceeds from Issuance of Long-term DebtUSD | — | 0Source | 0Source | 146,214,000Source |
| Proceeds from Stock Options ExercisedUSD | 11,578,000Source | 489,000Source | 32,000Source | 8,000Source |
income statement · annual statements
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|
| Total RevenueUSD | 291,845,000Source | 203,070,000Source | 163,914,000Source | 110,248,000Source |
| Selling, General and Administrative ExpenseUSD | 182,372,000Source | 163,481,000Source | 146,095,000Source | 137,745,000Source |
| Operating Income (Loss)USD | 24,896,000Source | -33,646,000Source | -44,010,000Source | -81,940,000Source |
| Other Nonoperating Income (Expense)USD | -24,342,000Source | -23,458,000Source | -19,494,000Source | -14,144,000Source |
| Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling InterestUSD | 554,000Source | -57,104,000Source | -63,504,000Source | — |
| Income Tax Expense (Benefit)USD | 0Source | -2,268,000Source | -1,249,000Source | -1,424,000Source |
| Net Income (Loss) Attributable to ParentUSD | 554,000Source | -54,836,000Source | -62,255,000Source | -94,660,000Source |
| Earnings Per Share, BasicUSD per share | 0Source | -0.37Source | -0.45Source | -0.7Source |
| Earnings Per Share, DilutedUSD per share | 0Source | -0.37Source | -0.45Source | -0.7Source |
| Weighted Average Number of Shares Outstanding, Basicshares | 160,425,198Source | 146,772,758Source | 137,674,857Source | 135,628,721Source |
| Weighted Average Number of Shares Outstanding, Dilutedshares | 172,742,720Source | 146,772,758Source | 137,674,857Source | 135,628,721Source |
| Interest Expense (non-operating)USD | 29,084,000Source | 30,485,000Source | — | — |
| Additional Financial Items | ||||
| Amortization of Intangible AssetsUSD | 10,843,000Source | 10,843,000Source | 10,843,000Source | 10,843,000Source |
| Cost of Goods and Service, Excluding Depreciation, Depletion, and AmortizationUSD | 42,569,000Source | 36,832,000Source | 28,645,000Source | 22,634,000Source |
| Income (Loss) Attributable to Parent, before TaxUSD | 554,000Source | -57,104,000Source | -63,504,000Source | -96,084,000Source |
| Income (Loss) from Continuing Operations before Income Taxes, DomesticUSD | -45,906,000Source | -78,408,000Source | -67,261,000Source | — |
| Interest ExpenseUSD | — | — | 26,609,000Source | 15,325,000Source |
| Interest Income, OtherUSD | 4,742,000Source | 5,321,000Source | 4,751,000Source | 2,578,000Source |
| Net Income (Loss) Available to Common Stockholders, BasicUSD | 554,000Source | — | — | — |
| Operating Costs and ExpensesUSD | 266,949,000Source | 236,716,000Source | 207,924,000Source | 192,188,000Source |
| Operating Lease, ExpenseUSD | 5,163,000Source | 5,276,000Source | 4,474,000Source | 1,799,000Source |
| Research and Development ExpenseUSD | 31,165,000Source | 25,560,000Source | 22,341,000Source | 20,966,000Source |